当前位置: X-MOL 学术Lancet Respir. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The role of CT in case ascertainment and management of COVID-19 pneumonia in the UK: insights from high-incidence regions.
The Lancet Respiratory Medicine ( IF 38.7 ) Pub Date : 2020-03-25 , DOI: 10.1016/s2213-2600(20)30132-6
Felix Chua 1 , Darius Armstrong-James 2 , Sujal R Desai 3 , Joseph Barnett 4 , Vasileios Kouranos 1 , Onn Min Kon 5 , Ricardo José 6 , Rama Vancheeswaran 7 , Michael R Loebinger 6 , Joyce Wong 8 , Maria Teresa Cutino-Moguel 9 , Cliff Morgan 10 , Stephane Ledot 10 , Boris Lams 11 , Wing Ho Yip 12 , Leski Li 13 , Ying Cheong Lee 13 , Adrian Draper 14 , Sze Shyang Kho 15 , Elisabetta Renzoni 1 , Katie Ward 16 , Jimstan Periselneris 17 , Sisa Grubnic 18 , Marc Lipman 19 , Athol U Wells 1 , Anand Devaraj 3
Affiliation  

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh pathogenic human coronavirus to be identified and the third with a predilection for causing potentially fatal pneumonia, after severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus. Coronavirus disease (COVID-19) infection is highly transmissible but has a relatively low death rate (1·0–3·5%), except in older people (aged >70 years) with comorbidities. It is estimated that 15–20% of people infected develop severe pneumonia and 5–10% require critical care.

中文翻译:


CT 在英国 COVID-19 肺炎病例查明和管理中的作用:来自高发地区的见解。



严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是已发现的第七种致病性人类冠状病毒,也是继严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒之后第三种容易引起潜在致命性肺炎的冠状病毒。冠状病毒病 (COVID-19) 感染具有高度传染性,但死亡率相对较低 (1·0–3·5%),但患有合并症的老年人(年龄 >70 岁)除外。据估计 15-20% 的感染者会发展为重症肺炎,5-10% 需要重症监护。
更新日期:2020-03-26
down
wechat
bug